BSPM [Biostar Pharmaceuticals,] UPLOAD:
[]
BSPM [Biostar Pharmaceuticals,] SC 13G: (Original Filing)
[bspm13g.txt 1 13G]
BSPM [Biostar Pharmaceuticals,] SC 13G: bspm13g.txt 1 13G
[bspm13g.txt 1 13G]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)
[December 17, 2010 405 Fifth Street, NW Gentlemen: 135 South State College Boulevard, Suite 300 | Brea, California 92821 | 714.990.1040 | frazerfrost.com Los Angeles and Visalia, CA | Little Rock and Fayetteville, AR | Raleigh, NC F R AZER FROST, LLP EX-16.1 2 v205591_ex16-1.htm] [NEWS RELEASE Skystar Bio-Pharmaceutical Appoints Crowe Horwath LLP as New Independent Auditor XI’AN, CHINA – December 15, 2010 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), To be added to the Company's email distribution for future news releases, please send your request to skystar@grayling.com. About Crowe Horwath About Skystar Bio-Pharmaceutical Company Skystar is a China-based developer and distributor]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: December 17, 2010 405 Fifth Street, NW Gentlemen:
[December 17, 2010 405 Fifth Street, NW Gentlemen: 135 South State College Boulevard, Suite 300 | Brea, California 92821 | 714.990.1040 | frazerfrost.com Los Angeles and Visalia, CA | Little Rock and Fayetteville, AR | Raleigh, NC F R AZER FROST, LLP EX-16.1 2 v205591_ex16-1.htm] [NEWS RELEASE Skystar Bio-Pharmaceutical Appoints Crowe Horwath LLP as New Independent Auditor XI’AN, CHINA – December 15, 2010 -- - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), To be added to the Company's email distribution for future news releases, please send your request to skystar@grayling.com. About Crowe Horwath About Skystar Bio-Pharmaceutical Company Skystar is a China-based developer and distributor]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)
[December 17, 2010 405 Fifth Street, NW Gentlemen: 135 South Statellege Boulevard, Suite 300 | Brea,lifornia 92821 | 714.990.1040 | frazerfrost.com Los Angeles and Visalia, | Little Rock and Fayetteville, AR | Raleigh, NC F R AZER FROST, v205591_ex16-1.htm 2 EX-16.1] [NEWS RELEASEystar Bio-Pharmaceutical Appoints Crowe Horwath New Independent Auditor XIAN, CHINA December 15, 2010 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"), To beded to thempany's email distribution for future news releases, please send your request toystar@grayling.com.out Crowe Horwathoutystar Bio-Pharmaceuticalmpany]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: December 17, 2010 405 Fifth Street, NW Gentlemen:
[December 17, 2010 405 Fifth Street, NW Gentlemen: 135 South Statellege Boulevard, Suite 300 | Brea,lifornia 92821 | 714.990.1040 | frazerfrost.com Los Angeles and Visalia, | Little Rock and Fayetteville, AR | Raleigh, NC F R AZER FROST, v205591_ex16-1.htm 2 EX-16.1] [NEWS RELEASEystar Bio-Pharmaceutical Appoints Crowe Horwath New Independent Auditor XIAN, CHINA December 15, 2010 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"), To beded to thempany's email distribution for future news releases, please send your request toystar@grayling.com.out Crowe Horwathoutystar Bio-Pharmaceuticalmpany]
TPI [TIANYIN PHARMACEUTICAL] CORRESP: (Original Filing)
[December 13, 2010 Division of Corporate Finance 100 F. Street, N.E. Attn: Mr. Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2009 File No. 001-34189 Dear Mr. Wyman: Very truly yours, LESER HUNTER TAUBMAN & TAUBMAN Attorney at Law cc: Dr. Jiang, Tianyin Pharmaceutical Co., Inc. CEO]
TPI [TIANYIN PHARMACEUTICAL] CORRESP: December 13, 2010 Division of Corporate Finance 100
[December 13, 2010 Division of Corporate Finance 100 F. Street, N.E. Attn: Mr. Wyman Re: Tianyin Pharmaceutical Co., Inc. Form 10-K for the Fiscal Year Ended June 30, 2009 File No. 001-34189 Dear Mr. Wyman: Very truly yours, LESER HUNTER TAUBMAN & TAUBMAN Attorney at Law cc: Dr. Jiang, Tianyin Pharmaceutical Co., Inc. CEO]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] DEF 14A: (Original Filing)
[Payment of Filing Fee (Check the appropriate box): x No fee required. o Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. 1) Title of each class of securities to which transaction applies:]
